Related Experiment Videos
[Autohemotransfusion in cardiac reoperations]
G M Actis Dato1, F Cirillo, A Actis Dato
1Istituzione Italiana di Cardiochirurgia, Torino.
Minerva Chirurgica
|November 1, 1993
Summary
Intraoperative autotransfusion with hemodilution (AHT) effectively reduces the need for banked blood transfusions after cardiac reoperations. This safe method also lowers risks of infectious disease transmission and immunologic reactions.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Anesthesiology
Context:
- Cardiac surgery reoperations present unique challenges regarding blood loss and transfusion requirements.
- Managing blood products in complex cardiac procedures is critical for patient outcomes.
- Intraoperative autotransfusion with hemodilution (AHT) is a technique to mitigate these challenges.
Purpose:
- To evaluate the efficacy of intraoperative autotransfusion with hemodilution (AHT) in reducing the need for postoperative transfusions of blood or blood products (BT).
- To assess the safety and hemorheologic benefits of AHT in patients undergoing cardiac surgery reoperations.
Summary:
- A retrospective study involving 169 patients undergoing cardiac reoperations evaluated the use of AHT.
- AHT involved reinfusing shed blood at the end of surgery, with a mean volume of 620.2 ml.
- Postoperative transfusion needs averaged 2.2 units, with minimal complications and one case of hepatitis B over a year of follow-up.
Impact:
- AHT demonstrates a significant reduction in the requirement for allogeneic blood transfusions.
- The technique is associated with decreased risks of infectious disease transmission and immunologic reactions.
- AHT offers hemorheologic advantages due to reduced blood viscosity, potentially improving patient recovery.